Loop VIII AAV Capsids for Transduction and Production Fitness
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing adeno-associated viral vectors face challenges in optimizing multiple traits such as high production yield and efficient targeting across species and organs, making them difficult to translate from preclinical to clinical use.
Innovation Solution
Development of adeno-associated virus (AAV) capsids with inserted peptides in specific regions, such as Loop VIII, enhancing transduction efficiency, production fitness, and biodistribution to target cells and organs like liver, brain, and heart.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a random library of peptide-modified capsids is funneled through multiple rounds of selection to identify top-performing candidates, then transduction efficiency to specific cell types is improved, but production yield and optimization across multiple traits deteriorate
Solution Approach 1:
The patent applies local quality by inserting peptides at specific loop regions (Loop VI, Loop VIII, Loop IX) of the AAV capsid structure. Rather than random modifications throughout the capsid, the invention targets specific local regions that are known to be involved in cellular interactions. This localized modification approach allows optimization of transduction efficiency to specific cell types while maintaining overall capsid stability and production yield, resolving the contradiction between specialized targeting and general manufacturability.
Solution Approach 2:
The patent employs parameter changes by systematically varying peptide sequences inserted at specific capsid loops. The invention tests multiple peptide variants with different amino acid compositions at defined positions, allowing optimization of transduction efficiency without requiring complete rescreening of the entire capsid structure. This parameter-based approach enables independent optimization of targeting properties while preserving production characteristics.
2Measurement precision
If capsids are optimized for one trait such as transduction efficiency, then performance for that specific function is improved, but optimization for other traits such as production yield and cross-species functionality deteriorates
Solution Approach 1:
The patent applies universality by designing peptide insertions that confer broad functionality across multiple species and cell types. The selected peptide sequences are chosen to interact with conserved cellular receptors or structures that are present across different species, enabling the capsid to maintain transduction efficiency in both preclinical models and human patients. This multi-functional design allows a single capsid variant to serve multiple purposes: efficient transduction, good production yield, and cross-species applicability.
Solution Approach 2:
The patent employs preliminary action by pre-selecting peptide sequences that have been computationally or empirically shown to possess desirable properties before insertion into the capsid. Rather than relying solely on random screening, the invention uses prior knowledge of successful peptide motifs and their effects on capsid function to guide the selection of insertions. This preliminary characterization allows prediction of cross-species functionality and production characteristics before full-scale optimization is attempted.
3Reliability
If the protein sequence space is sampled by chance to find rare variants enhanced across multiple traits, then comprehensive optimization is improved, but time and resources required for development increase significantly
Solution Approach 1:
The patent applies segmentation by dividing the capsid structure into distinct modular regions (different loops) that can be independently modified. Instead of attempting to screen the entire capsid sequence space randomly, the invention segments the optimization task into separate peptide insertion sites, each of which can be tested and optimized independently. This modular approach reduces the combinatorial complexity from searching the entire capsid sequence space to testing specific peptide variants at defined positions, dramatically reducing development time while maintaining reliability of multi-trait optimization.
Data Source
AI summary
The invention provides adeno-associated viral vectors and methods of using such vectors for cell transduction.